Highly Cited Researchers
Researcher among the most cited scientists in the world
Clinical Professor Asbjørn Hróbjartsson from Department of Clinical Research is among Clarivate's Highly Cited Researchers for the second year in a row.
If you're a patient in the healthcare system, you likely expect your treatment to be grounded in the best available knowledge – that there's solid evidence supporting it. Evidence, in this context, refers to the proven effectiveness of a particular approach. Moreover, evidence evolves over time as more insights are gained. This is precisely the aspect that Asbjørn Hróbjartsson contributes to ensuring.
Asbjørn Hróbjartsson has developed a significant international research profile in evidence-based medicine. His research centers on evaluating the quality of clinical research, with a specific focus on systematic reviews and clinical trials. He is dedicated to assessing and mitigating bias in clinical studies and has published extensively on various topics, including blinding, placebo, reporting bias, conflicts of interest, and guidelines for robust scientific reporting.
The research forms the foundation for ensuring that treatments and recommendations within the healthcare system are rooted in the most reliable evidence available. This, in turn, benefits both citizens and healthcare professionals.
Influential and interdisciplinary research
Asbjørn Hróbjartsson's publications rank among the most cited in his field. In fact, they are cited so frequently that they now reside within the top 1% in the 'cross-field' category on Web of Science.
Web of Science is a global database for researchers' citations, and for the second consecutive year, Asbjørn Hróbjartsson has been included in the list of the most cited researchers. Citations are categorized by publication year and subject area.
- I am, naturally, proud that so many find value in my research. However, the paramount goal is to draw attention to the ongoing commitment to seeking the best possible treatment, says Asbjørn Hróbjartsson.
Meet the researcher
Asbjørn Hróbjartsson is a clinical professor at the Department of Clinical Research, Center for Evidence-Based Medicine CEBMO and Cochrane Denmark.